SCHEMBL562684

SCHEMBL562684

NC1=NS(=O)(=O)N(Cc2ccc(Cl)cc2)c2nc(-c3ccccc3)n(Cc3ccc(Cl)cc3)c21

nearest known ligand 0.87

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.50
SMN1; SMN2 Q16637 4/20 0.50
CNR2 P34972 1/20 0.41
TNF P01375 1/20 0.41
CXCL8 P10145 1/20 0.41
SOS1 Q07889 1/20 0.41
NOD2 Q9HC29 1/20 0.41
NOD1 Q9Y239 1/20 0.41
LMNA P02545 4/20 0.40
RAB9A P51151 2/20 0.40
RECQL P46063 1/20 0.40
PDE6D O43924 1/20 0.40
ALDH2 P05091 1/20 0.40
ALDH3A1 P30838 1/20 0.40
TP53 P04637 2/20 0.39
DRD2 P14416 1/20 0.39
TBXA2R P21731 1/20 0.39
GALR3 O60755 1/20 0.38
NR2F2 P24468 1/20 0.38
PDE5A O76074 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL562165 0.99 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2CNR2TNFCXCL8
SCHEMBL563046 0.93 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2LMNARAB9ARECQL
SCHEMBL10018159 0.74 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2TNFCXCL8SOS1
SCHEMBL563386 0.72 KMT2A (0.43) ALDH1A1LMNARAB9APDE4APDE4B
SCHEMBL8801413 0.68 MAPT (0.37) ALDH1A1LMNAKDM4EMAPTKMT2A
SCHEMBL10018151 0.67 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2TNFLMNARAB9A
SCHEMBL11097622 0.65 ALDH1A1 (0.56) ALDH1A1SMN1; SMN2LMNARAB9ARECQL
SCHEMBL28261637 0.63 ALDH1A1 (0.91) ALDH1A1SMN1; SMN2CNR2TNFCXCL8
SCHEMBL562088 0.63 ADORA3 (0.36) ALDH1A1KDM4EMAPTPOLB
SCHEMBL11090546 0.63 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2CNR2LMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8815846-B2 Family of antichagasics derived from imidazo[4,5-C][1,2,6]thiadiazine 2,2-dioxide UNIVERSIDAD DE LA REPUBLICA DE URUGUAY (UY) 2014-08-26 US claimed
US-20120035160-A1 NEW FAMILY OF ANTICHAGASICS DERIVED FROM IMIDAZO[4,5-C][1,2,6]THIADIAZINE 2,2-DIOXIDE UNIVERSIDAD DE LA REPUB'LICA URUGUAY (UY) 2012-02-09 US claimed
EP-2392577-A1 NEW FAMILY OF ANTICHAGASICS DERIVED FROM IMIDAZO[4,5-C][1,2,6]THIADIAZINE 2,2-DIOXIDE Consejo Superior de Investigaciones Científicas (CSIC) (ES) 2011-12-07 EP claimed
US-8815846-B2 Family of antichagasics derived from imidazo[4,5-C][1,2,6]thiadiazine 2,2-dioxide UNIVERSIDAD DE LA REPUBLICA DE URUGUAY (UY) 2014-08-26 US disclosed
US-20120035160-A1 NEW FAMILY OF ANTICHAGASICS DERIVED FROM IMIDAZO[4,5-C][1,2,6]THIADIAZINE 2,2-DIOXIDE UNIVERSIDAD DE LA REPUB'LICA URUGUAY (UY) 2012-02-09 US disclosed
EP-2392577-A1 NEW FAMILY OF ANTICHAGASICS DERIVED FROM IMIDAZO[4,5-C][1,2,6]THIADIAZINE 2,2-DIOXIDE Consejo Superior de Investigaciones Científicas (CSIC) (ES) 2011-12-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035160-A1 NEW FAMILY OF ANTICHAGASICS DERIVED FROM IMIDAZO[4,5-C][1,2,6]THIADIAZINE 2,2-DIOXIDE THOC2, TUBGCP2, TBC1D5 ALDH1A1 1329/4885SMN1; SMN2 2009/4885CNR2 426/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.